Modern Chinese Medicine Group Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG6181B1068
HKD
0.50
-0.03 (-5.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
232.10
380.20
464.75
434.71
346.88
248.06
205.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
232.10
380.20
464.75
434.71
346.88
248.06
205.52
Raw Material Cost
172.50
265.58
266.82
244.46
193.50
135.83
118.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
14.75
17.35
19.53
22.14
15.27
12.83
12.38
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
0.02
0.09
0.28
0.00
0.00
Selling and Distribution Expenses
32.06
37.42
44.32
40.64
24.28
12.54
8.56
Other Expenses
-1.31
-1.57
-1.61
-0.96
-0.41
-0.34
-1.24
Total Expenditure (Excl Depreciation)
206.18
304.66
314.63
297.75
229.24
157.78
126.94
Operating Profit (PBDIT) excl Other Income
25.9
75.5
150.1
137
117.6
90.3
78.60000000000001
Other Income
-9.85
-0.06
-5.60
0.79
0.45
0.20
0.90
Operating Profit (PBDIT)
26.12
82.60
151.14
141.03
120.15
89.09
78.44
Interest
0.00
0.01
0.02
0.09
0.28
0.00
0.00
Exceptional Items
0.00
0.00
0.07
0.00
-16.14
-13.33
0.00
Gross Profit (PBDT)
59.60
114.62
197.93
190.26
153.38
112.24
87.14
Depreciation
10.06
7.12
6.62
3.28
2.06
1.76
2.03
Profit Before Tax
16.07
75.48
144.57
137.66
101.67
73.99
76.41
Tax
5.58
21.56
42.44
39.10
30.23
21.57
19.27
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10.48
53.92
102.13
98.56
71.44
52.43
57.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
10.48
53.92
102.13
98.56
71.44
52.43
57.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
10.48
53.92
102.13
98.56
71.44
52.43
57.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.01
0.01
0.0
0.0
0.0
Reserves
515.32
520.65
474.84
412.68
159.86
77.02
141.20
Earnings per share (EPS)
0.02
0.09
0.17
0.16
0.12
0.09
0.1
Diluted Earnings per share
0.02
0.09
0.17
0.16
0.12
0.09
0.1
Operating Profit Margin (Excl OI)
11.17%
19.87%
32.3%
31.51%
33.91%
35.12%
36.74%
Gross Profit Margin
11.25%
21.72%
32.53%
32.42%
29.9%
30.54%
38.17%
PAT Margin
4.52%
14.18%
21.98%
22.67%
20.6%
21.14%
27.8%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -38.95% vs -18.20% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -80.52% vs -47.21% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -56.47% vs -47.22% in Dec 2023

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Modern Chinese Medicine Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
232.10
532.09
-299.99
-56.38%
Other Operating Income
0.00
0.00
0.00
Total Operating income
232.10
532.09
-299.99
-56.38%
Raw Material Cost
172.50
276.56
-104.06
-37.63%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
14.75
0.00
14.75
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
4.95
-4.95
-100.00%
Selling and Distribution Expenses
32.06
271.45
-239.39
-88.19%
Other Expenses
-1.31
0.82
-2.13
-259.76%
Total Expenditure (Excl Depreciation)
206.18
561.11
-354.93
-63.25%
Operating Profit (PBDIT) excl Other Income
25.92
-29.02
54.94
189.32%
Other Income
-9.85
8.28
-18.13
-218.96%
Operating Profit (PBDIT)
26.12
-20.75
46.87
225.88%
Interest
0.00
4.95
-4.95
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
59.60
255.53
-195.93
-76.68%
Depreciation
10.06
0.00
10.06
Profit Before Tax
16.07
-25.69
41.76
162.55%
Tax
5.58
-0.69
6.27
908.70%
Provisions and contingencies
0
0
0.00
Profit After Tax
10.48
-24.16
34.64
143.38%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
10.48
-24.16
34.64
143.38%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-0.85
0.85
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10.48
-25.00
35.48
141.92%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
515.32
592.07
-76.75
-12.96%
Earnings per share (EPS)
0.02
-0.01
0.03
300.00%
Diluted Earnings per share
0.02
-0.01
0.03
300.00%
Operating Profit Margin (Excl OI)
11.17%
-5.45%
0.00
16.62%
Gross Profit Margin
11.25%
-4.83%
0.00
16.08%
PAT Margin
4.52%
-4.54%
0.00
9.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 23.21 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -38.95% vs -18.20% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 1.05 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -80.52% vs -47.21% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.60 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -56.47% vs -47.22% in Dec 2023

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.17%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023